| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/19/2014 | CN103596585A Formulations with reduced viscosity |
| 02/19/2014 | CN103589746A Building method of IL-7 immunologic adjuvant of giant panda interleukins 7 gene |
| 02/19/2014 | CN103589738A Modification of HIV-1 (Human immunodeficiency virus type one) Chinese epidemic strain CRF01_AE env gene |
| 02/19/2014 | CN103589693A Recombinant HVT (herpesvirus of turkey) expressing IBDV (infectious bursal disease virus) VP2 and bursin chimeric protein |
| 02/19/2014 | CN103589692A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 02/19/2014 | CN103589687A Tetrodo toxin neutralizing monoclonal antibody 5E7 hybridomas, genes of light-chain and heavy-chain variable regions thereof and applications |
| 02/19/2014 | CN103589656A Porcine contagious pleuropneumonia actinobacillus serum 1-type zinc ion binding protein A deletion strain, construction method therefor and applications thereof |
| 02/19/2014 | CN103588998A Polysaccharide/PEI nanogel with reduction responsiveness, preparation, and preparation method of polysaccharide/PEI nanogel |
| 02/19/2014 | CN103588881A Targeted binding agents directed to PDGFR-alpha and uses thereof |
| 02/19/2014 | CN103588878A Humanized anti-human-interleukin-1[belta] monoclonal antibody, preparation thereof and applications thereof |
| 02/19/2014 | CN103588875A Anti-Listeria monocytogenes Listeriolysin O monoclonal antibody and applications |
| 02/19/2014 | CN103588874A Human anti-HBV surface antigen genetic engineering antibody, and preparation method and application thereof |
| 02/19/2014 | CN103585643A Newcastle disease virus vectored avian vaccines |
| 02/19/2014 | CN103585631A Method for preventing and treating tumors by using microRNA sponge technology |
| 02/19/2014 | CN103585628A Immunoglobulin preparation for treating newcastle disease and preparation method thereof |
| 02/19/2014 | CN103585627A Preparation method for producing multiplied hyperimmune serum for dog by swine source |
| 02/19/2014 | CN103585626A Preparation method for newcastle disease and infectious bursal disease bigeminal composite inactivated vaccine |
| 02/19/2014 | CN103585625A Porcine epidemic diarrhea recombinant baculovirus gene engineering subunit vaccine, preparation method and application thereof |
| 02/19/2014 | CN103585624A 疫苗 Vaccine |
| 02/19/2014 | CN103585623A Vaccine comprising Streptococcus pneumoniae capsular polyaccharide conjugates |
| 02/19/2014 | CN103585622A Application of swine mycoplasma pneumonia vaccine strain |
| 02/19/2014 | CN103583841A Anti-goat-ecthyma antibody feed additive and preparation method thereof |
| 02/19/2014 | CN103583814A Anti-foot-and-mouth-disease antibody feed additive and preparation method thereof |
| 02/19/2014 | CN103583813A Anti-bluetongue antibody feed additive and preparation method thereof |
| 02/19/2014 | CN103041388B Piglet colibacillosis egg yolk immunoglobulin biological preparation and preparation process thereof |
| 02/19/2014 | CN103041385B Porcine transmissible gastroenteritis and epidemic diarrhea combined live vaccine and preparation method thereof |
| 02/19/2014 | CN103007280B Piglet colibacillosis lyophilized serum immunoglobulin preparation and preparation process thereof |
| 02/19/2014 | CN102532324B Preparation and application of brucella gene engineering subunit vaccines |
| 02/19/2014 | CN102389568B Vaccine for preventing golden pompano ulcer |
| 02/19/2014 | CN102356089B Meningococcal fhbp polypeptides |
| 02/19/2014 | CN102276726B Fusion protein of hepatocyte growth factor receptor active group |
| 02/19/2014 | CN102166228B A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 02/19/2014 | CN102050879B Anti-human CD20 humanized antibody and preparation method and application thereof |
| 02/19/2014 | CN101795708B Use of PCV2 antigen in preparing composition for reduction of concomitant infections in pigs |
| 02/19/2014 | CN101668539B Duck embryonic derived stem cell lines for the production of viral vaccines |
| 02/19/2014 | CN101605814B Engineered anti-TSLP antibody |
| 02/18/2014 | US8653244 Anti-epidermal growth factor receptor antibodies and uses thereof |
| 02/18/2014 | US8653243 Pertussis antibodies and uses thereof |
| 02/18/2014 | US8653242 Therapeutic antibodies against flagellated Pseudomonas aeruginosa |
| 02/18/2014 | US8653039 Peptide based inhibition of caPCNA interaction in cancer |
| 02/18/2014 | US8653034 Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives |
| 02/18/2014 | US8652839 HM1.24—utilizing cancer vaccines |
| 02/18/2014 | US8652822 Refrigerator-temperature stable influenza vaccine compositions |
| 02/18/2014 | US8652807 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 02/18/2014 | US8652546 Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals |
| 02/18/2014 | US8652504 Solid polymer delivery compositions and methods for use thereof |
| 02/18/2014 | US8652489 Therapeutic composition with a botulinum neurotoxin |
| 02/18/2014 | US8652488 Insulin B chain autoantigen composition |
| 02/18/2014 | US8652487 Tolerogenic synthetic nanocarriers for inducing regulatory B cells |
| 02/18/2014 | US8652486 Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications |
| 02/18/2014 | US8652485 Peptide for vaccine |
| 02/18/2014 | US8652483 Viral infection enhancing peptide |
| 02/18/2014 | US8652482 HPV E6 protein T cell epitopes and uses thereof |
| 02/18/2014 | US8652481 Mycoplasma bovis vaccine and methods of use thereof |
| 02/18/2014 | US8652480 Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides |
| 02/18/2014 | US8652479 Antibody-drug conjugates and methods |
| 02/18/2014 | US8652478 Method for treating cancer by administering antibody to ephrin type-A receptor 7 |
| 02/18/2014 | US8652477 Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation |
| 02/18/2014 | US8652476 Pharmaceutical composition for treating ischemic events |
| 02/18/2014 | US8652475 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 02/18/2014 | US8652474 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof |
| 02/18/2014 | US8652473 Antibodies to EGF receptor epitope peptides and uses thereof |
| 02/18/2014 | US8652472 Compositions and methods for diagnosing and treating cancer |
| 02/18/2014 | US8652471 Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitor |
| 02/18/2014 | US8652470 Monoclonal antibodies directed to CD52 |
| 02/18/2014 | US8652469 M-CSF-specific monoclonal antibody and uses thereof |
| 02/18/2014 | US8652468 Methods of binding TNF-α using anti-TNF-α antibody fragment-polymer conjugates |
| 02/18/2014 | US8652467 Dek protein compositions and methods of using the same |
| 02/18/2014 | US8652466 Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting |
| 02/18/2014 | US8652465 Methods and compositions for the treatment of persistent infections |
| 02/18/2014 | US8652462 Immune regulation |
| 02/18/2014 | US8652459 Splitting GP41 |
| 02/18/2014 | CA2674838C Anti-ige vaccines |
| 02/18/2014 | CA2601267C Novel anti-plgf antibody |
| 02/18/2014 | CA2589553C Use of flagellin in the immunotherapy of yersinia pestis |
| 02/18/2014 | CA2585011C Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 02/18/2014 | CA2577183C Mutated hiv nef for modulating immunity |
| 02/18/2014 | CA2576627C Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof |
| 02/18/2014 | CA2548310C Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 02/18/2014 | CA2538840C Dna vaccine compositions and methods of use |
| 02/18/2014 | CA2507898C Immunoglobulin variants and uses thereof |
| 02/18/2014 | CA2454756C Methods and compounds for the targeting of protein to exosomes |
| 02/18/2014 | CA2451741C Peyers's patch and/or m-celle targeting ligands |
| 02/18/2014 | CA2413450C Streptococcus antigens |
| 02/18/2014 | CA2403313C Potent t cell modulating molecules |
| 02/18/2014 | CA2359111C Improved saponin adjuvant compositions and methods relating thereto |
| 02/18/2014 | CA2331923C Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 02/13/2014 | WO2014026033A1 Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats |
| 02/13/2014 | WO2014025828A1 Engineered antibody fragments for targeting and imaging cd8 expression in vivo |
| 02/13/2014 | WO2014025813A1 Combination therapy for the treatment of glioblastoma |
| 02/13/2014 | WO2014025775A1 Treating allergic airway disorders using anti-il-20 receptor antibodies |
| 02/13/2014 | WO2014025767A1 Use of il-20 antagonists for treating liver diseases |
| 02/13/2014 | WO2014024965A1 Antigen peptide originated from t790m point-mutated sequence of epidermal growth factor receptor |
| 02/13/2014 | WO2014024026A1 Method for eliciting in infants an immune response against rsv and b. pertussis |
| 02/13/2014 | WO2014024024A1 Method for eliciting in infants an immune response against rsv |
| 02/13/2014 | WO2014023992A1 Plague vaccine |
| 02/13/2014 | WO2014023957A2 Anti-tumour response to modified self-epitopes |
| 02/13/2014 | WO2014023952A2 Prevention and treatment of osteoarthritis |
| 02/13/2014 | WO2014023816A1 Method for lowering the viscosity of high-concentration protein solutions |